Abstract
Introduction Hospitals are vital components of a country’s critical infrastructure, essential for maintaining resilient public services. Emergency planning for hospitals is crucial to ensure their functionality under special circumstances. The impact of climate change and seasonal variations in the utilization of hospital services further complicate emergency planning. Therefore, the knowledge of perennial disaster patterns could help strengthening the resilience of health care facilities.
Methods We conducted a cross-sectional analysis of the Emergency Events Database EM-DAT for disasters in Central Europe between January 2000 and December 2023 (defined as Germany and bordering countries). Primary endpoint was the average month of occurrence of disasters across the overall study period.
Results Out of 474 events, 83% were associated with a natural cause and only 80 events (=17%) were technological. More than 50 % of the technological disasters were categorized in the transport accident subgroup. Technological disasters were spread equally over the whole year. The vast majority of natural disasters (N=394) were due to storm (n=178, 45%), flood (n=101, 26%) and extreme temperatures (n=93, 24%) with peaks occurring during summer and winter months, while less disasters were registered during autumn and especially spring seasons.
Discussion Looking at the three most common disaster types, extreme temperatures, floods, and storms are clearly dominating and cause over 90% of the natural disasters in central Europe. An overlap of hospital admissions due to seasonal effects and catastrophic events, mainly triggered by natural disasters in the vulnerable periods may lead to a partial collapse of the health care system. To deal with such a variety of different and potentially simultaneous hazards using an “all hazards” approach could be promising and often has been seen as the most effective strategy for hospital emergency planning.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.